Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243938What this trial is testingPhase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)Who this might be right forLocally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (mCRC)+1 more Tao Zhang 70
Testing effectiveness (Phase 2)Looking for participantsNCT05671822What this trial is testingPh1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric CancerWho this might be right forHER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Testing effectiveness (Phase 2)Looking for participantsNCT07176312What this trial is testingZanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) PatientsWho this might be right forGastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Early research (Phase 1)Ended earlyNCT02757391What this trial is testingCD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsWho this might be right forColorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT02333188What this trial is testingGenetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAdenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more University of Chicago 50
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT07149090What this trial is testingLenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant AscitesWho this might be right forSTOMACH NEOPLASMGastric CancerGastric Cancer Adenocarcinoma Metastatic Asan Medical Center 61
Early research (Phase 1)Looking for participantsNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Testing effectiveness (Phase 2)UnknownNCT05095636What this trial is testingApatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerWho this might be right forGastric CancerMetastasis Fudan University 102
Testing effectiveness (Phase 2)UnknownNCT00005607What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusWho this might be right forEsophageal CancerGastric Cancer Robert H. Lurie Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06346197What this trial is testingCombination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric AdenocarcinomasWho this might be right forGastric CancerMSI-HMetastatic Cancer+1 more Centre Leon Berard 132
Testing effectiveness (Phase 2)Looking for participantsNCT05640609What this trial is testingCapeox Regimen Combined With Sintilimab and Bevacizumab for Gastric CancerWho this might be right forStomach Neoplasm West China Hospital 57
Early research (Phase 1)Temporarily pausedNCT04714983What this trial is testingDNX-2440 for Resectable Colorectal Liver MetastasisWho this might be right forLiver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more DNAtrix, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT04739202What this trial is testingPersonalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST)Who this might be right forGastric AdenocarcinomaMetastatic Gastric CancerMetastatic Adenocarcinoma+1 more Hospices Civils de Lyon 60
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46
Early research (Phase 1)Looking for participantsNCT07001592What this trial is testingIntra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal TumorsWho this might be right forGastric NeoplasmsEsophageal CancerLiver Cancer+9 more Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 18
Testing effectiveness (Phase 2)UnknownNCT04121039What this trial is testingStudy of the Apatinib Combine With POF Versus POF in Gastric CancerWho this might be right forGastric AdenocarcinomaAdvanced Cancer Fujian Cancer Hospital 116